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1. INTRODUCTION 
Lipoprotein lipase catalyses the hydrolysis of tri- 
acylglycerols and phospholipids in chylomicrons 
and very low density lipoproteins. This enables 
transport of fatty acids and of monoacylglycerols 
from the lipoproteins into the tissue cells [ 11. From 
in vitro experiments it is known that apolipopro- 
tein CII, which is a constituent of these lipopro- 
teins, is an activator for lipoprc;t.ein lipase [2,3]. 
That this activator has a function also in vivo is 
demonstrated by the fact that patients deficient in 
apolipoprotein CII accumulate large amounts of 
chylomicron-like lipoproteins in their blood [4]. 
The development of methods to purify both the 
lipase and the activator protein has made it possi- 
ble to study the mechanism of activation in de- 
lined model systems. In these systems lipoprotein 
lipase usually has significant activity even in the 
absence of its activator, and the activator causes a 
< IO-fold stimulation of the reaction rate [3,5-121. 
Studies using Intralipid [6], monolayers of di- 
acylglycerols [ 111, triacylglycerol-coated gjass 
beads [ 131, apolipoprotein CII-deficient very-low- 
density lipoproteins [14] and liposomes of di- 
palmitoyl phosphatidyl choline [ 151 have demon- 
strated that lipoprotein lipase binds to lipid-water 
interfaces. In these systems, the activator protein is 
not needed for the binding, and it has therefore 
been concluded that the activator acts after the en- 
zyme has bound to the interface [6,11,14]. This 
view is supported by experiments with non-lipid 
binding fragments of apolipoprotein CII which un- 
der certain circumstances activate the enzyme 
[9,10,14,16]. There are, however, some studies 
which indicate that the activator can also affect the 
binding of the lipase. Fielding [ 171, as well as 
Posner and Morrison [ 181 have reported that a 
mixture of apolipoproteins, including the activator, 
lowers the apparent Km of lipoprotein lipase for 
the lipid substrate. Schrecker and Greten found a 
lower apparent Km for triacylglycerol droplets sta- 
bilized by apolipoprotein CII than for droplets 
covered by CI or CIII, and concluded that this was 
because CII enhanced the binding of the lipase to 
the lipid droplets [19]. Matsuoka et al. [20], 
Fitzharris et al. [21] and Catapano et al. [ 141 found 
in studies with CII-deficient very-low-density 
lipoproteins, that the main effect of CII is to lower 
the apparent K,,, of lipoprotein lipase for its 
lipoprotein substrate. 
Since both lipoprotein lipase and apolipoprotein 
CII are lipid binding proteins and since a direct 
protein-protein interaction between lipoprotein 
lipase and its activator has been implicated by sev- 
eral studies [22-241, it would be expected that one 
protein could affect the binding of the other under 
certain circumstances. These considerations sug- 
gest that the full effect of CII is not seen in those 
model systems where the enzyme itself binds well 
to the lipid droplets. It was known that milk-fat 
globules are almost completely resistent o lipolysis 
by lipoprotein lipase as long as their structure is 
intact; large amounts of lipoprotein lipase are 
present in bovine milk but little or no lipolysis 
takes place [25]. Only small amounts of this lipase 
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are associated with the lipid droplets 1261. It has 
been demonstrated that addition of high-density 
lipoproteins induces rapid lipolysis in milk [27]. 
Here, we demonstrate that apolipoprotein CII 
causes an immediate activation of lipoprotein 
lipase in milk and that an important factor in this 
activation is to increase the binding of the enzyme 
to the milk fat globules. 
2. MATERIALS AND METHODS 
Milk was obtained from a dairy research farm in 
Umea. The cows were gently milked by hand. Un- 
less otherwise stated the milk was immediately 
cooled to 4°C. The milk was used for experiments 
within 6 h. Milk from several individual cows was 
tried without qualitative differences in the results. 
Lipoprotein lipase was purified from bovine milk 
as described 1281, and was iodinated by the lac- 
toperoxidase method as in 161. Apolipoproteins 
CII, CI and CIII-2 were prepared from delipidated 
human very-low-density lipoproteins by gel filtra- 
tion in 6 M guanidinium chloride followed by ion- 
exchange chromatography on diethylaminoethyl 
cellulose in 5 M urea (291. Apolipoprotein Al was 
prepared from delipidated human high-density 
lipoproteins [30]. The preparations were desalted 
by gel filtration in 2 M acetic acid and were then 
lyophilized. For the experiments the apolipopro- 
teins were dissolved in 3 M guanidinium chloride, 
20 mM Tris (pH 8.5). The protein concentration in 
these solutions was determined by quantitative 
amino acid analysis. In experiments without CII 
the same amount of guanidinium chloride buffer 
was added. Tl and T2 proteins from hen’s egg yolk 
were prepared as in [3 11. Triacylglycerol-rich parti- 
cles from Intralipid and from Intralipid-containing 
[3H]oleic acid labeled trioleoylglycerol (AB 
Vitrum, Stockholm) were isolated as in [6]. Bovine 
serum albumin (a fraction V preparation) and 
melittin were obtained from Sigma (St Louis MO). 
Conditions for the incubations are detailed in the 
legends. 
3. RESULTS 
In accord with 1251 there was no measurable 
lipolysis in milk which had been collected under 
gentle conditions, but rapid Iipolysis was induced 
by sonication of the milk (tig.1). Several other ma- 
nipulations/additions were tried but did not in- 
duce lipolysis. These included cooling the milk to 
4°C for 2 h and rewarming it to 37°C addition of 
60 mg albumin/ml, addition of 0.1 mg heparin/ml, 
addition of 1 PLg purified lipoprotein lipase/ml or 
adjustment of the pH of the milk to 8.5. Addition 
of apolipoprotein CII caused rapid lipolysis even 
in milk which had not been sonicated (tig.1). The 
rates obtained by sonication only or by CII only 
were similar, but combination of the two resulted 
in a higher activity (fig.1). The dose-response re- 
lation for activation by CII is shown in fig.2. Simi- 
lar amounts were needed with sonicated as with 
non-treated milk. In terms of fold stimulation, 
however, the results were more dramatic with the 
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Fig.1. Induction of lipolysis in fresh bovine milk by ad- 
dition of apolipoprotein CII and/or by mechanical 
treatment. Tubes containing 0.7 ml milk and 0.3 ml 
0.15 M NaCl were incubated at 37°C. After the times 
indicated the reaction was stopped by addition of 
organic solvents and the released fatty acids were deter- 
mined by titration (311. The amounts of fatty acids in 
corresponding blank samples (extracted at 0 min) were 
subtracted. Untreated milk (m). Milk sonicated for 2 min 
with a Branson sonifer immediately before the incuba- 
tion (0). Milk to which 17.6 pg apolipoprotein CII/ml 
was added immediately before the incubation (0). Milk 
which was sonicated for 2 min and to which 17.6 rg apo- 
lipoprotein CII/ml was then added (A). For this experi- 
ment the milk was collected from the cow into a thermos 
flask and was then kept at -30°C until the incubations 
were started, - 1 h. Similar results were obtained if the 
milk had been cooled to 4°C before the experiment or if 
heat-inactivated. milk was used to which purified 
lipoprotein lipase was added. 
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untreated milk because of the low activity without 
CII. 
When incubated with a synthetic lipid emulsion 
such as Intralipid, lipoprotein lipase binds to the 
lipid droplets and the complex can be flotated by 
centrifugation ([6] and table 1). In. contrast, no 
lipase bound to the milk-fat globules (table 1). 
This was not because some other component in the 
milk prevented the binding; when Intralipid was 
added to the milk, 70% of the 1251-labeled lipopro- 
tein lipase and 65% of the enzyme activity floated 
on centrifugation. Thus, the lack of binding to the 
milk fat globules must relate to their structure. Ad- 
dition of apolipoprotein CII to the milk caused the 
enzyme to bind to the milk-fat globules. This is 
illustrated by the experiment in table 1, where 16% 
of the radioactive enzyme and 12% of the enzyme 
activity was recovered with the lipid droplets when 
the system contained CII compared to < 1% in the 
absence of CII. Centrifugation of sonicated milk 
demonstrated lipase radioactivity and enzyme 
I- 
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Fig.2. Dose-response curves for the stimulation by apo- 
lipoprotein Cl1 of lipolysis in untreated milk and in 
sonicated milk, respectively. For this experiment the 
lipoprotein lipase in the milk was first inactivated by 
heating the milk for 15 min at 60°C. Then one part of 
this milk was chilled in ice-water and sonicated for 
4 min with a Branson sonifer. For the incubations 5 d 
apolipoprotein CII (4.4 mg/ml) or logarithmic dilutions 
of Cl1 in 3 M guanidinium chloride was added to I ml 
of milk. After 5 min at 25”C, the reactions were started 
by addition of 2.5 pg purified lipoprotein lipase. Then 
the reactions were carried out for 10 min at 25°C; (0) 
not sonicated milk, the activity without apolipoprotein 
Cl1 was 0.03 pmol fatty acid/ml; (o) sonicated milk, the 
activity without Cl1 was 1.23 pmol fatty acid/ml. 
Table 1 
Effect of apolipoprotein Cl1 on the binding of lipo- 
protein lipase to milk-fat globules 
Lipid 
source 
Apolipo- 
protein 
CII 
Radioactivity 
(%) in top 
phase 
Enzyme 
activity 
(W) in top 
phase 
Milk - <l <l 
+ 16 12 
lntralipid - 92 70 
+ 85 72 
+ Milk - 70 65 
+ 72 61 
1 ml heat-inactivated milk (see fig. 2 legend) or 1 ml 
0.15 M NaCl was mixed with 0.45 ml bovine serum al- 
bumin (100 mg/ml) in 0.5 M Tris-HCI buffer (pH 8.0) 
in a total volume of 1.5 ml. As indicated some samples 
contained 8 rg apolipoprotein Cl1 and/or centrifuged 
lntralipid corresponding to 6 mg triacylglycerol. Sucrose 
(150 mg) was dissolved in each sample. A trace amount 
of t251-labeled lipoprotein lipase (15 000 cpm, 30 ng) 
and 1.5 PLg unlabeled lipoprotein lipase was added. Each 
sample (1 ml) was layered under 4 ml 0.15 M NaCl, 
10 mM Tris-HCl (pH 8.0) containing 1 mg bovine 
serum albumin/ml in tubes for ultracentrifugation. The 
tubes were centrifuged 25 000 rev./min, 20 min at 15°C 
in a Beckman SW50.1 rotor. The top 1 ml layer con- 
taining a thin lipid cake was recovered after slicing the 
tubes. The lipoprotein lipase activity in the top phases 
was determined by incubation of 10~1 samples in an 
assay mixture containing JH-labeled lntralipid with 
human serum as source of activator protein [6]. The en- 
zyme activities are expressed as 5% of the activity in the 
non-centrifuged starting mixture. The radioactivity in 
the top phases is expressed as % of the total radioactivity 
in the tube. The total recovery of radioactivity after cen- 
trifugation and tube-slicing was >85%. Blank samples 
were run without lipid substrates. They gave typically 
- 3% of the t251-radioactivity and no measurable 
lipase activity in the top phase. These blank values 
were subtracted 
activity in the fat layer, but quantification of the 
binding was not possible since some of the lipid 
did not flotate under the conditions used. Similar 
experiments were carried out with human apolipo- 
proteins AI, CI and CIII-2, with porcine colipase 
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and with melittin. None of these proteins caused the activator proteins enhance the activity of pan- 
any lipolysis. However, both Tl and T2 proteins creatic lipase and of lipoprotein lipase, respec- 
from egg-yolk lipoproteins caused lipolysis. Thus, tively, both mechanisms may operate in both sys- 
the effect seems to be specific for proteins known tems and the analogies may be much closer than 
to activate lipoprotein lipase in model systems. realized. 
4. DISCUSSION 
We conclude that with milk-fat globules as the 
substrate, the main factor determining the activity 
of lipoprotein lipase is the extent to which the en- 
zyme can bind to the lipid droplets, and that apo- 
lipoprotein CII facilitates the binding. These con- 
clusions are in apparent contrast to several recent 
studies which have emphasized that lipoprotein 
lipase binds almost completely to lipid-water in- 
terfaces even in the absence of activator protein 
[6,11,15]. These studies have led to the view that 
the effect of the activator protein is to enhance the 
catalytic efficiency of enzyme already bound to the 
lipid-water interface [6,9,11,16]. These data do not 
invalidate this conclusion but demonstrate another 
aspect of the CII-lipoprotein lipase interaction. 
The binding effect and the effect on the catalytical 
efficiency are not mutually exclusive. Which as- 
pect dominates depends on the nature of the sub- 
strate being used. With intact milk-fat globules 
there was virtually no binding and no activity of 
lipoprotein lipase in the absence of apolipoprotein 
CII. The dramatic stimulation was probably due to 
a dual effect of the activator protein, enhancing 
both binding and catalytic efficiency. When the 
native structure of the milk-fat globules was dis- 
rupted by sonication, rapid lipolysis ensued and 
the activator caused only 2-fold further increase in 
the rate. This modest effect of the activator was 
probably due to stimulation of the catalytic effi- 
ciency only, as has been demonstrated in the 
model systems (6,111. 
We cannot yet define what is the property that 
prevents binding of lipoprotein lipase to the milk- 
fat globules. However, it is apparent that the resis- 
tance of the milk-fat globules to lipolysis is biolog- 
ically advantageous since it prevents breakdown of 
the droplets within the mammary gland. It may 
well be generally true that the need for the activa- 
tor apolipoprotein restricts the activity of lipo- 
protein lipase to those plasma lipoproteins which 
carry the activator and prevents the enzyme from 
acting on other tissue lipids such as intracellular 
triglyceride droplets. 
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